1. Home
  2. RCKT vs SFST Comparison

RCKT vs SFST Comparison

Compare RCKT & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • SFST
  • Stock Information
  • Founded
  • RCKT 1999
  • SFST 1999
  • Country
  • RCKT United States
  • SFST United States
  • Employees
  • RCKT N/A
  • SFST N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • SFST Major Banks
  • Sector
  • RCKT Health Care
  • SFST Finance
  • Exchange
  • RCKT Nasdaq
  • SFST Nasdaq
  • Market Cap
  • RCKT 326.4M
  • SFST 285.9M
  • IPO Year
  • RCKT N/A
  • SFST 1999
  • Fundamental
  • Price
  • RCKT $2.48
  • SFST $38.34
  • Analyst Decision
  • RCKT Buy
  • SFST Buy
  • Analyst Count
  • RCKT 13
  • SFST 1
  • Target Price
  • RCKT $18.50
  • SFST $43.00
  • AVG Volume (30 Days)
  • RCKT 4.7M
  • SFST 17.4K
  • Earning Date
  • RCKT 08-04-2025
  • SFST 07-17-2025
  • Dividend Yield
  • RCKT N/A
  • SFST N/A
  • EPS Growth
  • RCKT N/A
  • SFST 37.29
  • EPS
  • RCKT N/A
  • SFST 2.25
  • Revenue
  • RCKT N/A
  • SFST $97,501,000.00
  • Revenue This Year
  • RCKT N/A
  • SFST $4.07
  • Revenue Next Year
  • RCKT N/A
  • SFST $8.99
  • P/E Ratio
  • RCKT N/A
  • SFST $17.03
  • Revenue Growth
  • RCKT N/A
  • SFST 11.95
  • 52 Week Low
  • RCKT $2.19
  • SFST $27.65
  • 52 Week High
  • RCKT $26.98
  • SFST $45.91
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 31.96
  • SFST 56.38
  • Support Level
  • RCKT $2.50
  • SFST $35.15
  • Resistance Level
  • RCKT $2.70
  • SFST $37.89
  • Average True Range (ATR)
  • RCKT 0.20
  • SFST 0.91
  • MACD
  • RCKT 0.11
  • SFST 0.10
  • Stochastic Oscillator
  • RCKT 4.82
  • SFST 81.66

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

Share on Social Networks: